These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20197475)

  • 1. Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient.
    Roustit M; Blondel E; Villier C; Fonrose X; Mallaret MP
    Ann Pharmacother; 2010 Apr; 44(4):764-7. PubMed ID: 20197475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hypoglycemia from clarithromycin-repaglinide drug interaction.
    Khamaisi M; Leitersdorf E
    Pharmacotherapy; 2008 May; 28(5):682-4. PubMed ID: 18447665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects.
    Niemi M; Kajosaari LI; Neuvonen M; Backman JT; Neuvonen PJ
    Br J Clin Pharmacol; 2004 Apr; 57(4):441-7. PubMed ID: 15025742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible trimethoprim/sulfamethoxazole-induced aseptic meningitis.
    Therrien R
    Ann Pharmacother; 2004 Nov; 38(11):1863-7. PubMed ID: 15367724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions to trimethoprim/sulfamethoxazole in AIDS.
    Floris-Moore MA; Amodio-Groton MI; Catalano MT
    Ann Pharmacother; 2003 Dec; 37(12):1810-3. PubMed ID: 14632594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.
    Raz R; Chazan B; Kennes Y; Colodner R; Rottensterich E; Dan M; Lavi I; Stamm W;
    Clin Infect Dis; 2002 May; 34(9):1165-9. PubMed ID: 11941541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probable trimethoprim/sulfamethoxazole-induced higher-level gait disorder and nocturnal delirium in an elderly man.
    Dakin LE
    Ann Pharmacother; 2009 Jan; 43(1):129-33. PubMed ID: 19109207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperkalemia associated with high-dose trimethoprim-sulfamethoxazole in a patient with the acquired immunodeficiency syndrome.
    Mihm LB; Rathbun RC; Resman-Targoff BH
    Pharmacotherapy; 1995; 15(6):793-7. PubMed ID: 8602391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ofloxacin versus trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infection.
    Cox CE; Serfer HS; Mena HR; Briefer C; Childs SJ; Gordon SF; Zoller JS
    Clin Ther; 1992; 14(3):446-57. PubMed ID: 1638586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repaglinide and diabetes: new preparation. No better than glucose-lowering sulphonamides.
    Prescrire Int; 2001 Feb; 10(51):9-11. PubMed ID: 11503861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antidiabetic drug at every meal. Repaglinide is especially recommended for slender type 2 diabetic patients].
    Landgraf R
    MMW Fortschr Med; 2000 Jul; 142(28-29):29-30. PubMed ID: 10959157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim-sulfamethoxazole (TMP/SMX) potentiates indinavir nephrotoxicity.
    de Araujo M; Seguro AC
    Antivir Ther; 2002 Sep; 7(3):181-4. PubMed ID: 12487385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memantine-induced myoclonus and delirium exacerbated by trimethoprim.
    Moellentin D; Picone C; Leadbetter E
    Ann Pharmacother; 2008 Mar; 42(3):443-7. PubMed ID: 18303133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of trimethoprim-sulfamethoxazole on blood insulin and glucose concentrations of diabetics.
    Mihic M; Mautner LS; Feness JZ; Grant K
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):80-2. PubMed ID: 1137831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim-sulfamethoxazole-induced hyponatremia.
    Dunn RL; Smith WJ; Stratton MA
    Consult Pharm; 2011 May; 26(5):342-9. PubMed ID: 21733815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
    Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life threatening hyperkalemia and acidosis secondary to trimethoprim-sulfamethoxazole treatment.
    Margassery S; Bastani B
    J Nephrol; 2001; 14(5):410-4. PubMed ID: 11730276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent pancreatitis after trimethoprim-sulfamethoxazole rechallenge.
    Versleijen MW; Naber AH; Riksen NP; Wanten GJ; Debruyne FM
    Neth J Med; 2005; 63(7):275-7. PubMed ID: 16093580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe hypoglycaemia from repaglinide-brotizolam drug interaction: a case report and literature review.
    Khamaisi M
    Diabet Med; 2012 Sep; 29(9):1214-5. PubMed ID: 22414218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.